Aubrey Haddach Named Co-Chair of ABA’s Biotechnology Law Committee

August 9, 2017News Releases

Dinsmore & Shohl LLP attorney Aubrey Haddach has accepted her appointment to serve as co-chair of the American Bar Association’s Biotechnology Law Committee for the 2017-2018 bar year. Haddach had been the committee’s vice-chair since March.

With more than 400,000 members, the American Bar Association is one of the largest voluntary professional membership organizations in the world. The Biotechnology Law Committee, part of the ABA Section of Science & Technology, keeps the public informed on an array of topics relating to biotechnology, including research, regulatory, patent, and clinical medicine issues. Throughout the year, the committee identifies important policies issues and writes articles for the SciTech Lawyer and Jurimetrics Journal. Its members also respond to requests for input on resolutions relevant to their specialties.

“The Biotechnology Law Committee has long been the crown jewel of the section so the opportunities and relationships can be incredibly rewarding,” said Haddach. “I hope to use my role as co-chair to enhance biotechnology law and better serve the public’s understanding of it.”

Haddach, a member of Dinsmore’s Intellectual Property Department, represents clients ranging from small businesses to Fortune 500 companies. She has experience in all aspects of patent law and related business matters in the U.S. and around the world. She began her career in the labs of biotech and pharmaceutical companies, having worked as both a medicinal and process research chemist.